Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03692546Completed
Randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Orthopaedic & Neurosurgery Specialists. Primary endpoint: Daily Opioid Consumption in Oral Morphine Equivalent at Day 5. Started Feb 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03692546.